Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nicotine and the nicotinic cholinergic system in COVID‐19
Yousef Tizabi, Bruk Getachew, Robert Copeland, et al.
FEBS Journal (2020) Vol. 287, Iss. 17, pp. 3656-3663
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Drug repurposing for COVID-19 via knowledge graph completion
Rui Zhang, Dimitar Hristovski, Dalton Schutte, et al.
Journal of Biomedical Informatics (2021) Vol. 115, pp. 103696-103696
Open Access | Times Cited: 161
Nicotine in Inflammatory Diseases: Anti-Inflammatory and Pro-Inflammatory Effects
Wenji Zhang, Hui‐Ching Lin, Mingmin Zou, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 80
COVID-19: Why does disease severity vary among individuals?
Saeed Samadizadeh, Maha Masoudi, Mostafa Rastegar, et al.
Respiratory Medicine (2021) Vol. 180, pp. 106356-106356
Open Access | Times Cited: 90
Smoking and COVID-19: A Scoping Review
Chadia Haddad, Sandrella Bou Malhab, Hala Sacre, et al.
Tobacco Use Insights (2021) Vol. 14
Open Access | Times Cited: 65
A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptors
A. Sofia F. Oliveira, Amaurys Ávila Ibarra, Isabel Bermúdez, et al.
Biophysical Journal (2021) Vol. 120, Iss. 6, pp. 983-993
Open Access | Times Cited: 62
COVID-19-Related Mortality Risk in People With Severe Mental Illness: A Systematic and Critical Review
Marc D. Binder, Victor Mazereel, Marc Stroobants, et al.
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 57
Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 474-474
Open Access | Times Cited: 8
A Systematic Review and Meta-Analysis of Hospitalised Current Smokers and COVID-19
Jesús González-Rubio, Carmen Navarro-López, Elena López-Nájera, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 20, pp. 7394-7394
Open Access | Times Cited: 65
Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin
Guilherme Dias de Melo, Françoise Lazarini, Florence Larrous, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 8
Open Access | Times Cited: 48
Disorders of the Cholinergic System in COVID-19 Era—A Review of the Latest Research
Marta Kopańska, Marta Batoryna, Paulina Bartman, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 672-672
Open Access | Times Cited: 28
Cholinergic dysfunction in COVID-19: frantic search and hoping for the best
Eman Hassan Nadwa, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 396, Iss. 3, pp. 453-468
Open Access | Times Cited: 28
Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes
Fabrizio Maggi, Alfredo Rosellini, Pietro Giorgio Spezia, et al.
ERJ Open Research (2021) Vol. 7, Iss. 2, pp. 00713-2020
Open Access | Times Cited: 34
Novel Pharmacotherapies in Parkinson’s Disease
Yousef Tizabi, Bruk Getachew, Michael Aschner
Neurotoxicity Research (2021) Vol. 39, Iss. 4, pp. 1381-1390
Open Access | Times Cited: 34
Role of Glial Cells and Receptors in Schizophrenia Pathogenesis
Yousef Tizabi, Marta C. Antonelli, Daniela Tizabi, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Closed Access
Nicotinic Acetylcholine Receptors in the Respiratory Tract
Monika I. Hollenhorst, Gabriela Krasteva‐Christ
Molecules (2021) Vol. 26, Iss. 20, pp. 6097-6097
Open Access | Times Cited: 30
Alcohol- and Cigarette-Use Related Behaviors During Quarantine and Physical Distancing Amid COVID-19 in Indonesia
Enjeline Hanafi, Kristiana Siste, Albert Prabowo Limawan, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 29
Toxin-like Peptides from the Bacterial Cultures Derived from Gut Microbiome Infected by SARS-CoV-2—New Data for a Possible Role in the Long COVID Pattern
Carlo Brogna, Simone Cristoni, Barbara Brogna, et al.
Biomedicines (2022) Vol. 11, Iss. 1, pp. 87-87
Open Access | Times Cited: 19
The smoker’s paradox during the COVID-19 pandemic? The influence of smoking and vaping on the incidence and course of SARS-CoV-2 virus infection as well as possibility of using nicotine in the treatment of COVID-19 – Review of the literature
Anna Korzeniowska, Gabriela Ręka, Małgorzata Bilska, et al.
Przeglad Epidemiologiczny (2021) Vol. 75, Iss. 1, pp. 27-44
Open Access | Times Cited: 23
Toxin-like peptides in plasma, urine and faecal samples from COVID-19 patients
Carlo Brogna, Simone Cristoni, Mauro Petrillo, et al.
F1000Research (2021) Vol. 10, pp. 550-550
Open Access | Times Cited: 23
COVID-19 and Alzheimer’s Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future
Giuseppina Amadoro, Valentina Latina, Egidio Stigliano, et al.
Cells (2023) Vol. 12, Iss. 22, pp. 2601-2601
Open Access | Times Cited: 9
The Exposome and Immune Health in Times of the COVID-19 Pandemic
Javier S. Morales, Pedro L. Valenzuela, Adrián Castillo‐García, et al.
Nutrients (2021) Vol. 14, Iss. 1, pp. 24-24
Open Access | Times Cited: 21
SARS-Cov-2 spike protein fragment 674–685 protects mitochondria from releasing cytochrome c in response to apoptogenic influence
Olena Kalashnyk, Olena Lykhmus, Mykhailo Izmailov, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 561, pp. 14-18
Open Access | Times Cited: 18
Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial
Guylaine Labro, Florence Tubach, Lisa Belin, et al.
Intensive Care Medicine (2022) Vol. 48, Iss. 7, pp. 876-887
Open Access | Times Cited: 13
Twitter discourse on nicotine as potential prophylactic or therapeutic for COVID-19
Ramakanth Kavuluru, Jiho Noh, Shyanika W. Rose
International Journal of Drug Policy (2021) Vol. 99, pp. 103470-103470
Open Access | Times Cited: 16
Cigarettes' use and capabilities-opportunities-motivation-for-behavior model: a multi-country survey of adolescents and young adults
Heba Jafar Sabbagh, Wafaa Abdelaziz, Maryam Quritum, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top